首页> 外文期刊>World Journal of Gastroenterology >Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil
【24h】

Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil

机译:巴西北部人群胃腺癌中CDH1,FHIT,MTAP和PLAGL1的启动子高甲基化

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To evaluate the methylation status of CDH1, FHIT, MTAP and PLAGL1 promoters and the association of these findings with clinico-pathological characteristics. METHODS: Methylation-specific PCR (MSP) assay was performed in 13 nonneoplastic gastric adenocarcinoma, 30 intestinal-type gastric adenocarcinoma and 35 diffuse-type gastric adenocarcinoma samples from individuals in Northern Brazil. Statistical analyses were performed using the chi-square or Fisher's exact test to assess associations between methylation status and clinico-pathological characteristics. RESULTS: Hypermethylation frequencies of CDH1, FHIT, MTAP and PLAGL1 promoter were 98.7%, 53.9%, 23.1% and 29.5%, respectively. Hypermethylation of three or four genes revealed a significant association with diffuse-type gastric cancer compared with nonneoplastic cancer. A higher hypermethylation frequency was significantly associated with H pylori infection in gastric cancers, especially with diffuse-type. Cancer samples without lymph node metastasis showed a higher FHIT hypermethylation frequency. MTAP hypermethylation was associated with H pylori in gastric cancer samples, as well as with diffuse-type compared with intestinal-type. In diffuse-type, MTAP hypermethylation was associated with female gender. CONCLUSION: Our findings show differential gene methylation in tumoral tissue, which allows us to conclude that hypermethylation is associated with gastric carcinogenesis. MTAP promoter hypermethylation can be characterized as a marker of diffuse-type gastric cancer, especially in women and may help in diagnosis, prognosis and therapies. The H pylori infectious agent was present in 44.9% of the samples. This infection may be correlated with the carcinogenic process through the gene promoter hypermethylation, especially the MTAP promoter in diffuse-type. A higher H pylori infection in diffuse-type may be due to greater genetic predisposition.
机译:目的:评估CDH1,FHIT,MTAP和PLAGL1启动子的甲基化状态,以及这些发现与临床病理特征的关系。方法:在巴西北部的13例非肿瘤性胃腺癌,30例肠型胃腺癌和35例弥散型胃腺癌样本中进行了甲基化特异性PCR(MSP)分析。使用卡方检验或Fisher精确检验进行统计分析,以评估甲基化状态与临床病理特征之间的关联。结果:CDH1,FHIT,MTAP和PLAGL1启动子的超甲基化频率分别为98.7%,53.9%,23.1%和29.5%。与非肿瘤性癌症相比,三个或四个基因的高度甲基化显示与弥漫型胃癌显着相关。较高的高甲基化频率与胃癌中的幽门螺杆菌感染显着相关,尤其是与弥漫性感染有关。没有淋巴结转移的癌症样品显示较高的FHIT高甲基化频率。 MTAP甲基化与胃癌样本中的幽门螺杆菌相关,以及与肠型相比与扩散型相关。在弥散型中,MTAP甲基化与女性有关。结论:我们的发现表明肿瘤组织中存在差异基因甲基化,这使我们可以得出结论,甲基化与胃癌发生有关。 MTAP启动子高甲基化可被表征为弥漫型胃癌的标志物,尤其是在女性中,并可有助于诊断,预后和治疗。幽门螺杆菌感染因子存在于44.9%的样品中。通过基因启动子的超甲基化,尤其是弥散型的MTAP启动子,这种感染可能与致癌过程有关。弥漫型幽门螺杆菌感染率较高可能是由于遗传易感性较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号